Challenges in prevention, diagnosis and therapy of emerging fungal diseases. Aspergillosis: A case study

Heart Diseases


Diseases caused by pathogenic filamentous fungi, are an emerging threat to public health in the wake of increasing incidence of HIV and tuberculosis. At this point, discovery and development of fungal therapeutics and diagnostics are serious challenges for biomedical researchers. Recent technological advances in genomics and proteomics offer great scope for development of preventive and therapeutic measures for fungal diseases.Aspergillus, one of the medically important filamentous pathogenic fungi causes a wide spectrum of clinical disorders ranging from allergic aspergillosis to systemic invasive aspergillosis. Increase in incidence of drug resistance and the cytotoxic effects are two serious limitations of the antifungal drugs presently in use. This is primarily due to lack of understanding of biological mechanisms operative in these fungi. Today, it is possible to understand the biological mechanisms of the fungus for its colonisation, survival and invasion of the host. Future developments based on such leads can result in development of precise and specific diagnostic, therapeutic and preventive measures for a wide clinical spectrum of fungal diseases.

Key Words

Fungal diseases aspergillosis pathogenesis genomics proteomics host's susceptibility 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mitchell, T.G. (2000) Overview of Basic Medical Mycology. Otolaryngol. Clin. North. Amer. 33, 237–249.CrossRefGoogle Scholar
  2. 2.
    Sarma, P.U., Banerjee, B., Bir, N. and Kurup, V.P. (1998)A. fumigatus antigen and Immunodiagnosis of ABPA. Immunol. Allergy Clin. Nor. Amer. 18, 525–547.CrossRefGoogle Scholar
  3. 3.
    Kurup, V.P., Banerjee, B., Kelly, K.J. and Fink JN. (2000) Molecular biology and immunology of fungal allergens Ind. J. Clin. Biochem. 15 (Suppl), 31–42.Google Scholar
  4. 4.
    Bir, N., Paliwal, A., Muralidhar, K. and Sarma, P.U. (1999) Biochemical characterisation of an immunodominant allergen/antigen ofA. fumigatus. Ind. J. Clin. Biochem. 14, 149–158.Google Scholar
  5. 5.
    Madan, T., Arora, N. and Sarma P.U. (1997) Ribonuclease activity dependent cytotoxicity ofAsp fl. Mol. Cell. Biochem. 175, 21–27.PubMedCrossRefGoogle Scholar
  6. 6.
    Madan, T., Arora, N. and Sarma, P.U. (1997) Cytotoxicity of Asp fl, of a major allergen/antigen ofA. fumigatus. Mol. Cell. Biochem. 167, 89–97.PubMedCrossRefGoogle Scholar
  7. 7.
    Sarma, P.U., Bir, N., Paliwal, A. and Prasad Reddy, T.L. (1997) Immunopolymerase chain reaction for detection ofAspergillus fumigatus. Ind. J. Clin. Biochem. 12, 101–106.Google Scholar
  8. 8.
    Banerjee, B., Madan, T., Sharma, G.L., Prasad, H.K., Nath, I. and Sarma, P.U. (1995) Characterisation of 45 kD glycoprotein antigen ofA. fumigatus. Serodiag. Immunother. Infect. Dis. 7, 147–152.CrossRefGoogle Scholar
  9. 9.
    Madan, T., Banerjee, B., Bhatnagar, P.K., Shah, A. and Sarma, P.U. (1997) Identification of 45 kD antigen in immune complexes of patients of Allergic bronchopulmonary aspergillosis. Mol. Cell. Biochem. 166, 111–116.PubMedCrossRefGoogle Scholar
  10. 10.
    Kolattukudy, P.E., Lee, J.D., Rogers, L.M., Zimmerman, P., Ceselski, S., Fox, B., Stein, B. and Copelan, E.A. (1993) Evidence for possible involvement of an elastinolytic serine protease in aspergillosis. Infect. Immun. 6, 2357–2363.Google Scholar
  11. 11.
    Kothari, M.H., Chase, T. and Macmillan, J.D. (1984) Correlation of elastase production by some strains ofAspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect. Immun. 43, 320–325.Google Scholar
  12. 12.
    Smith, J.M., Tang, C.M., Noorden, S.V. and Holden, D.W. (1994) Virulence ofAspergillus fumigatus double mutants lacking restrictocin and an alkaline protease in a low dose model of invasive aspergillosis. Infect. Immun. 62, 5247–5252.PubMedGoogle Scholar
  13. 13.
    Chou, H., Lin, W.L., Tam, M.F., Wang, S.R., Han, S.H. and Shen, H.D. (1999) Alkaline serine proteinase is a major allergen ofAspergillus flavus, a prevalent airborneAspergillus species in the Taipei area. Int. Arch. Allergy. Immunol. 119, 282–290.PubMedCrossRefGoogle Scholar
  14. 14.
    Palmer, L.B., Greenberg, H.E. and Schiff, M.J. (1991) Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax. 46, 15–20.PubMedCrossRefGoogle Scholar
  15. 15.
    Purkayastha, S., Madan, T., Shah, A., Krishnamurthy, H.G. and Sarma, P.U. (2000) Multifunctional antigens ofA. fumigatus and specific antibodies. App. Biochem. Biotech. 83, 271–284.CrossRefGoogle Scholar
  16. 16.
    Singh, P., Kumar, P., Bhagi, R.P. and Singla, R. (1989) Pulmonary aspergilloma-radiological observations. Ind. J. Chest. Dis. Allied. Sci. 31, 177–185.Google Scholar
  17. 17.
    Van Ommen, G.J.B., Bakker, E. and den Dunnen, J.T. (1999) The human genome project and the future of diagnostics, treatment, and prevention. Lancet. 354, 5–10.CrossRefGoogle Scholar
  18. 18.
    Wilkins, M. (2000) Proteomic paradigms for perceiving purpose. TIBTECH 18, 91–92.Google Scholar
  19. 19.
    Bellamy, R. (1998) Genetics and pulmonary medicine. 3. Genetic susceptibility to tuberculosis in human populations. Thorax. 53, 588–593.PubMedCrossRefGoogle Scholar
  20. 20.
    Bellamy, R., Ruwende, C., Corrah, T., McAdam, K.P., Whittle, H.C. and Hill, A.V. (1998) Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. New Engl. J. Med. 338, 640–644.PubMedCrossRefGoogle Scholar
  21. 21.
    Chauhan, B., Knutsen, A.P., Hutcheson, P.S., Slavin, R.G. and Bellone, C.J. (1996) T cell subsets, Epitope mapping and HLA-restriction in patients with ABPA. J. Clin. Invest. 97, 2324–2331.PubMedCrossRefGoogle Scholar
  22. 22.
    Knutsen, A.P., Hutcheson, P.S., Mueller, K.R. and Slavin, R.G. (1990) Serum immunoglobulins G anti-Aspergillus fumigatus antibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis. J. Lab. Clin. Med. 116, 724–727.PubMedGoogle Scholar
  23. 23.
    Miller, P.W., Hamosh, A., Macek, M. Jr., Greenberger, P.A., Maclean, J., Walden, S.M., Slavin, R.G. and Cutting, G.R. (1996) Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Amer. J. Hum. Genet. 59, 45–51.PubMedGoogle Scholar
  24. 24.
    Madan, T., Eggleton, P., Kishore, U., Aggarwal, S.S., Sarma, P.U. and Reid, K.B.M. (1997) Binding of pulmonary surfactant protein A and D toAspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and macrophages. Infect. Immun. 65, 3171–3179.PubMedGoogle Scholar
  25. 25.
    Madan, T., Kishore, U., Eggleton, P., Aggarwal, S.S., Sarma, P.U. and Reid, K.B.M. (1997) Interaction of lung surfactant protein SP-A and SP-D with allergens ofAspergillus fumigatus. J. Clin. Exp. Immunol. 110, 241–249.CrossRefGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2000

Authors and Affiliations

  • P. Usha Sarma
    • 1
  • P V G K Sarma
    • 2
  • Taruna Madan
    • 1
  1. 1.Centre for Biochemical TechnologyDelhiIndia
  2. 2.Department of Biochemical TechnologySri Venkateswara CollegeNew Delhi

Personalised recommendations